Page last updated: 2024-10-16

beta-alanine and Dermatitis

beta-alanine has been researched along with Dermatitis in 2 studies

Dermatitis: Any inflammation of the skin.

Research Excerpts

ExcerptRelevanceReference
" Plasma level of intact SC-57461 (3 h after oral gavage dosing with 3 mg/kg) was 0."1.31Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies. ( Askonas, LJ; Ghoreishi-Haack, N; Kachur, JF; Liang, CD; Russell, MA; Smith, WG; Villani-Price, D; Won-Kim, S, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhang, S1
Edwards, TN1
Chaudhri, VK1
Wu, J1
Cohen, JA1
Hirai, T1
Rittenhouse, N1
Schmitz, EG1
Zhou, PY1
McNeil, BD1
Yang, Y1
Koerber, HR1
Sumpter, TL1
Poholek, AC1
Davis, BM1
Albers, KM1
Singh, H1
Kaplan, DH1
Kachur, JF1
Askonas, LJ1
Villani-Price, D1
Ghoreishi-Haack, N1
Won-Kim, S1
Liang, CD1
Russell, MA1
Smith, WG1

Other Studies

2 other studies available for beta-alanine and Dermatitis

ArticleYear
Nonpeptidergic neurons suppress mast cells via glutamate to maintain skin homeostasis.
    Cell, 2021, 04-15, Volume: 184, Issue:8

    Topics: Animals; beta-Alanine; Cells, Cultured; Dermatitis; Diphtheria Toxin; Disease Models, Animal; Female

2021
Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:2

    Topics: Administration, Oral; Administration, Topical; Animals; Arthus Reaction; beta-Alanine; Dermatitis; E

2002